|
Early provocative data is demonstrating that platinum compounds (e.g. cisplatin and carboplatin) particularly in combination with other agents have an important role to play in the treatment of breast cancer. These agents may soon be used routinely in the adjuvant setting for this condition according to researchers speaking at the Second Annual "Future of Breast Cancer: An International Breast Cancer Congress."
|